| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.011 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0098 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |